Artivion to Participate in Upcoming Investor Conferences
Artivion (AORT) will participate in investor conferences on November 10 and November 11, 2026, with management presenting at both events.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Artivion (AORT) will participate in investor conferences on November 10 and November 11, 2026, with management presenting at both events.
The Stifel 2026 Healthcare Conference presentation begins at 11:20 a.m. ET; the 20th Annual Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum presentation begins at 8:00 a.m. ET. Both will be webcast on Artivion's Investors page, with replays available for 90 days.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Artivion's management team will present at the upcoming Stifel 2026 Healthcare Conference on Tuesday, November 10, 2026 at the Lotte New York Palace Hotel. The Company's presentation is scheduled to begin at 11:20 a.m. ET. The management team will also present at the upcoming 20th Annual Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on Wednesday, November 11, 2026 at the Westin New York Grand Central Hotel. The Company's presentation is scheduled to begin at 8:00 a.m. ET.
A live webcast of both presentations can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcasts will be available for 90 days on the same website.
About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc., is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.
Contacts:
|
Artivion |
Gilmartin Group LLC |
|---|---|
|
Lance A. Berry |
Brian Johnston |
|
Executive Vice President, |
Phone: 332-895-3222 |
|
Chief Operating Officer & |
investors@artivion.com |
|
Chief Financial Officer |
|
|
Phone: 770-419-3355 |
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302922646.html
SOURCE Artivion, Inc.